Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has informed the exchanges that it will host an earnings and analysts conference call on Monday, August 11, 2025 at 12:00 PM (IST) to discuss the un-audited financial results for Q1 FY26. The call is being organised in coordination with Ambit Capital, which will moderate the discussion. Senior management including Managing Directors Sanjeev Jain and Sandeep Jain, CFO Sumeet Sood, and Head of Strategy Sahil Maheshwari will represent the company. The disclosure was filed on August 5, 2025, under SEBI Listing Regulations, and dial-in details have been shared with the exchanges and posted on the company's website.
This is a routine intimation and does not itself contain any financial numbers or material developments, so it is unlikely to move the stock on its own. However, investors should watch the August 11 call for Q1 FY26 revenue, margins, and management commentary on business outlook, which could influence short-term sentiment.